{
  "trial_id": "NCT00082017",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Relapsed or refractory systemic Anaplastic Large Cell Lymphoma (ALCL)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Relapsed or refractory mature T-cell lymphoma to include peripheral T-cell lymphoma",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Adult T-cell lymphoma; Extranodal natural killer (NK)/T-cell lymphoma, nasal type; Enteropathy-type T-cell lymphoma;",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Hepatosplenic T-cell lymphoma; Subcutaneous panniculitis-like T-cell lymphoma; Angioimmunoblastic T-cell lymphoma.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "All patients should have evaluable or measurable disease on entry to study.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Histology confirmed by Laboratory of Pathology, National Cancer Institute (NCI).",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Performance Status Eastern Cooperative Oncology Group (ECOG) less than or equal to 2.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Age 7 years or older.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Creatinine less than or equal to 1.5 mg/dl or creatinine clearance greater than 50 ml/min for patients at least 18 years.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Pediatric patients should have maximum serum creatinine by age as follows: Less than age 7 and less than or equal to age 10 may have a Maximum Serum Creatinine of 1.0 mg/dl; Less than age10 and less than or equal to age 15 may have a Maximum Serum Creatinine of 1.2 mg/dl; Age 15 years or older may have a Maximum Serum Creatinine of 1.5 mg/dl.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Alternatively, pediatric patients should have a creatinine clearance of greater than 50 m1/min/1.73m^2.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Total bilirubin less than 1.5 x upper limit of normal (ULN) (patients with elevation of total bilirubin consistent with Gilbert's disease are eligible providing they have a normal direct bilirubin).",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "aspartate aminotransferase (AST) less than or equal to 2.5 x ULN;",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "No active central nervous system (CNS) lymphoma.",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "Patients should not have received systemic cytotoxic chemotherapy within 3 weeks of study entry.",
      "label": "triggers",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has a history of anaplastic astrocytoma and is currently experiencing progressive lower extremity weakness and urinary retention. The patient's age and performance status are within the eligible range.",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT00082017",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}